Lam Research (NASDAQ:LRCX) Trading Down 1.8% – Time to Sell?

Shares of Lam Research Corporation (NASDAQ:LRCX) traded down 1.8% during trading on Friday . The stock traded as low as $153.20 and last traded at $159.35. 11,587,415 shares changed hands during mid-day trading, a decline of 2% from the average session volume of 11,863,616 shares. The stock had previously closed at $162.19.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on LRCX shares. Susquehanna boosted their price target on shares of Lam Research from $135.00 to $200.00 and gave the company a “positive” rating in a report on Thursday, October 23rd. Stifel Nicolaus set a $160.00 target price on Lam Research and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Berenberg Bank boosted their target price on shares of Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. JPMorgan Chase & Co. increased their target price on shares of Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 23rd. Finally, The Goldman Sachs Group upped their price objective on shares of Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $148.54.

Lam Research Trading Down 1.8%

The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The business’s fifty day moving average is $133.76 and its two-hundred day moving average is $105.64. The firm has a market cap of $200.15 billion, a price-to-earnings ratio of 35.10, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period last year, the company earned $0.86 EPS. The business’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. Lam Research’s dividend payout ratio is presently 22.91%.

Insider Transactions at Lam Research

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the transaction, the director directly owned 1,652 shares in the company, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 62,498 shares of company stock worth $8,875,663 in the last quarter. 0.31% of the stock is owned by company insiders.

Hedge Funds Weigh In On Lam Research

Several hedge funds have recently added to or reduced their stakes in the stock. Brighton Jones LLC boosted its stake in Lam Research by 1,032.4% during the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after acquiring an additional 12,936 shares during the last quarter. TD Private Client Wealth LLC increased its position in shares of Lam Research by 13.4% in the 1st quarter. TD Private Client Wealth LLC now owns 6,285 shares of the semiconductor company’s stock valued at $457,000 after buying an additional 743 shares in the last quarter. U.S. Capital Wealth Advisors LLC raised its stake in Lam Research by 5.1% during the 1st quarter. U.S. Capital Wealth Advisors LLC now owns 5,902 shares of the semiconductor company’s stock worth $429,000 after buying an additional 289 shares during the period. Greenleaf Trust lifted its holdings in Lam Research by 2.2% during the first quarter. Greenleaf Trust now owns 55,108 shares of the semiconductor company’s stock worth $4,006,000 after acquiring an additional 1,196 shares in the last quarter. Finally, Axxcess Wealth Management LLC increased its holdings in shares of Lam Research by 34.8% in the first quarter. Axxcess Wealth Management LLC now owns 10,663 shares of the semiconductor company’s stock worth $775,000 after acquiring an additional 2,753 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.